D. Anderson & Company Appoints Teddie S. Garrigan Executive Vice President

December 05, 2007 (PRLEAP.COM) Health News
D. Anderson & Company (DAC), a subsidiary of D.L. Anderson International, announced today that noted corporate strategist Teddie S. Garrigan has been named executive vice president.

With more than 25 years of experience spanning the full spectrum of strategic planning, Ms. Garrigan will lead DACís project operations department, as well as directly contribute to the companyís overall growth in the patient recruitment and retention field.

She is a recognized expert in analyzing dynamics that affect growth initiatives in domestic and international markets. Ms.Garrigan most recently provided counsel to DAC regarding issues management, focusing on internal and external factors that affect the companyís growth.

"Teddie has spent the greater part of 2007 working closely with us as a consultant and we are excited to bring her on board," said DAC president and CEO Diana L. Anderson, Ph.D. "We are confident that her track record of success in strategic planning, combined with her experience in managing large global projects, will help the company continue to position itself as the leader in patient recruitment and retention in the clinical trials industry."

Ms. Garrigan was executive vice president and chief strategic officer for The Herman Group of Companies, providing counsel and long-range planning efforts surrounding projects in emerging Middle Eastern markets. As president and CEO of Dallas-based strategic advisory firm Seaborn Communications, Inc., she provided communications services in public relations, marketing, media relations and corporate affairs.

"I am pleased to be joining such a high-caliber organization and look forward to continuing DACís tradition of providing innovative and efficient approaches to clinical trials management," Ms. Garrigan said.

About D. Anderson & Company:
D. Anderson & Company (DAC) is a leading global provider of patient recruitment and retention services for the clinical trials industry with more than 17 years of experience in more than 33 countries. DAC evolved from a clinical background as a site management organization (SMO), giving the company a unique understanding of how sites operate and what they need to reach enrollment goals within targeted timelines. DAC combines strategic marketing, messaging and branding solutions with proven, data-driven methodologies to create targeted patient recruitment campaigns for some of the most prestigious pharmaceutical and biotechnology companies in the world. DAC is a certified Women-Owned Business (WBE) by the Womenís Business Enterprise National Council and is based in Dallas. For more information, visit http://www.dandersoncompany.com/.